Bains has resigned from the position of MD & CEO with effect from the close of business hours on June 30, Syngene International said in a regulatory filing.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/YdApZaN
via IFTTT
-
Lilly's Mounjaro has rapidly become the second-highest selling drug in India's pharmaceutical market, achieving ₹233 crore in sales ...
-
The Indian Pharmaceutical Alliance lauds the upcoming GST reforms, effective Monday, as a transformative step towards affordable healthcare....
-
India's Syngene International has agreed to acquire its first biologics facility in the U.S. from Emergent Manufacturing for $36.5 milli...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2026
(523)
-
▼
July
(78)
- TPG, Permira emerge as frontrunners in Rs 11,000 c...
- Lupin launches generic Sugammadex injection in US
- As we look to the next decade, I hope in the futur...
- ChrysCapital acquires controlling 70.68% stake in ...
- ChrysCapital acquires controlling 70.68% stake in ...
- FSSAI suspends licence of Dior Pharmaceuticals for...
- Gland Pharma gets USFDA nod for generic sugammadex...
- Biocon gets Health Canada nod for Yesintek autoinj...
- BDR Pharmaceuticals eyes controlling stake in Acme...
- Andhra Pradesh teams up with AstraZeneca for next-...
- Alembic Pharma gets USFDA approval for generic chr...
- Sakar Healthcare posts Rs 10-crore profit in Q1
- Centre readies healthcare compliance overhaul to b...
- PHC Mogla brings healthcare closer to Rajouri's re...
- US tariff proposal wake-up call for Indian pharma ...
- Sculpt, lift, glow: Face fitness is having a momen...
- Aster DM Quality Care to invest Rs 1,315 crore in ...
- AstraZeneca 'magic' faces rare test after trial fa...
- FSSAI suspends Rehaan Healthcare licence over seri...
- Jackson Labs seeks restoration of its licence
- India contributes one-third of global oral cancer ...
- Trump's 200% generic drug tariff threat puts $9.7 ...
- Dr Reddy’s aims to resume semaglutide supply by No...
- Trump's Generic Drug Tariffs Explained: What it me...
- Trump announces new generic drugs tariff plan: No ...
- ICMR licenses cancer, vaccine technologies to Emcu...
- Glenmark sees innovative products driving 70% reve...
- Glenmark gets USFDA nod for expanded use of RYALTR...
- Japanese drugmaker Takeda's Qdenga becomes first d...
- Emcure Pharma gets CDSCO nod to market Poviztra fo...
- Takeda Biopharmaceuticals gets DCGI nod for dengue...
- Alcon to step up India investments; focus on innov...
- Alembic Pharma partner NATCO gets USFDA tentative ...
- Novo Nordisk's obesity drug Wegovy wins India appr...
- Screens are straining young eyes, and Alcon sees I...
- Poly Medicure bets on new facilities, products to ...
- Pharma exports to UK may rise up to 10% in FY27 as...
- India-UK FTA projected to boost Indian pharma expo...
- NITI Aayog roadmap targets USD 691 bn bioeconomy b...
- Kota kidney damage victims seek euthanasia or trea...
- Warburg Pincus buys Mumbai’s pharma company Integr...
- Jitendra Singh releases Rs 1,500 crore under third...
- Warburg Pincus buys Mumbai’s pharma company Integr...
- Sun Pharma gets SAHPRA approval for generic semagl...
- OneSource Specialty Pharma partners with Formycon ...
- FDA approves at-home starter dose of Eisai-Biogen ...
- Warburg, Bain, CVC among PE firms in talks to buy ...
- Emcure buys remaining 12.05% in Gennova to take fu...
- First vaccine for Bundibugyo Ebola hits human tria...
- Schedule H1 explained: Why did India tighten its p...
- Pharma body renews push for data protection
- Antibiotic resistance emerging as major threat to ...
- Maharashtra FDA bars sale of two Cadila drugs over...
- Medicines with over 12% alcohol can no longer be s...
- Dr Reddy’s pauses weight loss drug on quality fears
- GA-Renova & CCA in race to buy American oncology: ...
- Dr Reddy's flags quality issue in semaglutide batc...
- Novo Nordisk readies once-a-week insulin shot for ...
- Cultural sensitivity, communication key to strengt...
- Navi Mumbai Airport notified as port for import of...
- Regulator seeks views to curb similar sounding dru...
- India's wellness industry poised for growth amid f...
- Gene therapy firm Immuneel ties up with Arogya Fin...
- Glenmark launches generic Olanzapine injection in US
- Death in a vial: Five cases lay bare many uncomfor...
- Adani Group to set up 2,000-bed hospital in New To...
- OnCare launches cancer treatment centre in Bengaluru
- Fortis Healthcare inks pact with Dion Group for 30...
- Sun Pharma secures relief in 'Pantocid' trademark ...
- Syngene International MD & CEO Peter Bains resigns
- Zydus Lifesciences ties up with Apollo Hospitals t...
- New rules simplify drug launches, reduce manufactu...
- Shantha Biologics to make injectable drug cartridg...
- Generics must not be imperiled over data protectio...
- Telangana bets big on drug discovery hub
- Mankind Pharma partners Denovo Sciences for AI-led...
- mRNA vaccines protect against severe infectious di...
- Mankind Pharma joins hands with Denovo Sciences fo...
-
▼
July
(78)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment